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Abstract
Objective:  to  identify  possible  risk  factors  associated  with  wheezing  in  infants  (12-15  months-
old) in  the  state  of  Mato  Grosso,  Brazil.
Methods:  this  was  a  cross-sectional  study  performed  by  applying  a  standardized  written  ques-
tionnaire  from  the  international  study  on  wheezing  in  infants  (Estudio  Internacional  de  Sibilancia
en  Lactantes  -  EISL),  phase  3.  Parents  and/or  guardians  of  infants  were  interviewed  at  primary
health  care  clinics  or  at  home  from  August  of  2009  to  November  of  2010.  Factors  associated  to
wheezing  were  studied  using  bivariate  and  multivariate  analysis  (using  the  Statistical  Package
for  Social  Sciences  [SPSS]  v.18.0),  and  expressed  as  odds  ratios  (OR)  and  95%  conﬁdence  intervals
(95%  CI).
Results:  the  written  questionnaire  was  answered  by  1,060  parents  and/or  guardians.  The  risk
factors  for  wheezing  were:  history  of  asthma  in  the  family  [mother  (OR  =  1.62;  95%  CI  =  1.07-
2.43);  father  (OR  =  1.98;  95%  CI  =  1.22-3.23);  siblings  (OR  =  2.13;  95%  CI  =  1.18-3.87)];  history
of  previous  pneumonia  (OR  =  10.80;  95%  CI  =  4.52-25.77);  having  had  more  than  six  upper
respiratory  tract  infections  (URTIs)  (OR  =  2.95;  95%  CI  =  2.11-4.14);  having  had  ﬁrst  URTI  before
the  third  month  of  life  (OR  =  1.50;  95%  CI  =  1.04-2.17);  living  in  a  moderately  polluted  area
(OR  =  1.59;  95%  CI  =  1.08-2.33);  paracetamol  use  for  URTI  (OR  =  2.13;  95%  CI  =  1.54-2.95);  and
antibiotic  use  for  skin  infection  (OR  =  2.29;  95%  CI  =  1.18-4.46).
Conclusions:  the  study  of  risk  factors  for  wheezing  in  the  ﬁrst  year  of  life  is  important  to  help
physicians identify  young  children  at  high  risk  of  developing  asthma  and  to  improve  public  health
prevention  strategies  in  order  to  reduce  the  morbidity  of  wheezing  in  childhood.
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Fatores  de  risco  associados  à  sibilância  em  lactentes
Resumo
Objetivo:  identiﬁcar  possíveis  fatores  de  risco  associados  à  sibilância  em  lactentes  (12  a  15
meses)  no  estado  de  Mato  Grosso,  Brasil.
Métodos:  estudo  transversal,  utilizando  o  questionário  escrito  padronizado  do  Estudio  Inter-
nacional de  Sibilancia  en  Lactantes  (EISL)  --  fase  3.  Pais  e/ou  responsáveis  pela  crianc¸a foram
entrevistados  em  Unidades  Básicas  de  Saúde  quando  as  procuravam  para  imunizac¸ão  de  rotina
ou  durante  visitas  nos  domicílios  de  crianc¸as  matriculadas  nos  programas  de  saúde  da  família,
no  período  de  agosto  de  2009  a  novembro  de  2010.  Fatores  associados  à  sibilância  foram  avali-
ados  utilizando  análise  bivariada  e  multivariada  e  expressos  como  odds  ratio  (OR)  e  intervalo
de  conﬁanc¸a 95%  (IC95%).
Resultados: ao  todo,  um  mil  e  sessenta  (n  =  1.060)  pais  e/ou  responsáveis  responderam  o
questionário escrito.  Os  fatores  de  risco  para  sibilância  foram:  história  familiar  de  asma  [mãe
(OR  =  1,62;  IC95%=  1,07-2,43);  pai  (OR  =  1,98;  IC95%  =  1,22-3,23);  irmãos  (OR  =  2,13;  IC95%  =
1,18-3,87)];  história  prévia  de  pneumonia  (OR  =  10,8;  IC  95%  =  4,52-25,77);  ter  mais  de  seis
infecc¸ões  de  vias  aéreas  superiores  (IVAS)  (OR  =  2,95;  IC95%  =  2,11-4,14)  e  a  primeira  IVAS  antes
dos  três  meses  de  idade  (OR  =  1,50;  IC95%  =  1,04-2,17);  residir  em  local  com  moderada  poluic¸ão
(OR =  1,59;  IC95%  =  1,08-2,33);  uso  de  paracetamol  por  IVAS  (OR  =  2,13;  IC95%  =  1,54-2,95);  e
uso  de  antibiótico  por  infecc¸ão  na  pele  (OR  =  2,29;  IC  95%  =  1,18-4,46).
Conclusões:  O  estudo  dos  fatores  de  risco  para  sibilância  no  primeiro  ano  de  vida  é  importante
para auxiliar  na  identiﬁcac¸ão,  entre  os  lactentes  sibilantes,  aqueles  de  alto  risco  para  desen-
volver  asma,  e  para  o  desenvolvimento  de  estratégias  de  prevenc¸ão  por  políticas  pública  de
saúde  visando  minimizar  a  morbidade  da  sibilância  na  infância.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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heezing  in  infants  is  an  important  cause  of  morbidity
orldwide, both  in  developed  and  developing  countries.1
ome  wheezing  phenotypes  have  been  described  as  associ-
ted with  different  risk  factors.2 In  infants  and  preschool
hildren, the  asthma  diagnosis  is  based  on  clinical  symp-
oms, presence  of  risk  factors,  and  therapeutic  response;
herefore, the  identiﬁcation,  among  wheezing  infants,  of
hose at  high  risk  for  developing  asthma  is  crucial  to  deﬁne
hich children  will  beneﬁt  from  preventive  or  therapeutic
nterventions.3
Prospective  studies  suggest  several  risk  factors  for  early
heezing in  children  and  its  association  with  the  subsequent
evelopment of  asthma,  such  as  family  history  of  allergy,4
ersonal  history  of  rhinitis  or  eczema,5,6 maternal  smok-
ng during  pregnancy  or  passive  exposure  after  birth,7 male
ender,2,5 viral  respiratory  infections  by  respiratory  syncytial
irus (RSV)  or  rhinovirus,8,9 and  attending  daycare.10 Epi-
emiological studies  have  observed  an  association  between
he development  of  asthma  and  regular  use  of  medications
uch as  paracetamol  and  antibiotics  during  infancy.11,12
Therefore,  risk  factors  for  wheezing  in  infants  have
een identiﬁed,  but  their  analysis  is  complex,  due  to  the
enetic-environmental interactions.  The  development  of
ethods to  identify  and  quantify  these  factors  is  essential
or better  understanding  the  natural  history  of  asthma  in
hildhood. The  epidemiology  of  asthma  is  known  worldwide
n school-age  children,  adolescents,  and  adults;  however,
he prevalence  and  risk  factors  associated  with  symptoms
f recurrent  wheezing  in  infants  and  preschool  children  are
till under  investigation.13
w
(
rTo  assess  the  impact  of  recurrent  wheezing  in  infants  and
etermine its  prevalence  and  associated  risk  factors,  the
nternational Study  of  Wheezing  in  Infants  in  the  ﬁrst  year
f life  (Estudio  Internacional  de  Sibilancias  en  Lactantes  -
ISL) was  developed.  This  is  an  international  multicenter
tudy with  the  participation  of  Latin  American  countries,
pain, and  the  Netherlands,  whose  tool  was  a standardized
uestionnaire validated  in  all  participating  centers.  Phase
 of  EISL  used  a  standardized  questionnaire  with  45  ques-
ions on  demographic  characteristics,  respiratory  symptoms,
se of  medications,  and  possible  risk  factors  associated  with
heezing.1 Phase  2  was  designed  to  verify  the  onset  and  per-
istence of  wheezing  in  preschoolers  among  the  children  who
articipated in  Phase  1,  and  the  centers  that  participated
ave not  yet  published  their  results.  Phase  3  was  designed  to
e conducted  ﬁve  years  after  Phase  1  in  the  same  region,  to
ompare the  trend  in  prevalence  in  relation  to  Phase  1  data,
nd it  used  the  same  questionnaire  as  in  Phase  1,  including
ve questions  on  the  use  of  antibiotics  and  paracetamol  in
rst months  of  life,  totaling  50  questions.
This  study  aimed  to  evaluate  risk  factors  associated  with
heezing in  infants  in  Midwestern  Brazil,  using  the  standard-
zed protocol  of  EISL  - Phase  3.
atients and methods
arents  or  guardians  of  healthy  infants  aged  12  to  15  months
ho answered  the  standard  written  questionnaire  of  EISL
QE-EISL) -  Phase  3  participated  in  the  study.
Among  the  60  basic  health  units  (BHUs)  distributed  in  four
egions -  North,  South,  East  and  West  -  of  the  city,  28  were
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randomly  selected  for  the  study.  Parents  and/or  guardians
were invited  to  participate  when  they  came  for  consultation
and routine  immunization  of  their  children,  or  during  visits
to households  of  all  children  aged  12  to  15  months  enrolled  in
the Family  Health  Program  of  the  BHUs.  All  parents  and/or
guardians agreed  to  participate,  signed  an  informed  con-
sent, and  were  then  interviewed  by  the  main  investigator  or
a previously  trained  medical  student.  Visits  to  the  BHUs  or
homes occurred  between  August  of  2009  and  November  of
2010; during  the  two  immunization  campaigns  against  polio
performed during  this  period,  all  children  who  belonged  to
the target  age  group  that  came  on  the  day  of  the  campaign
participated in  the  study.
The  QE-EISL  -  phase  3  is  a  tool  consisting  of  50  ques-
tions regarding  demographic  characteristics,  wheezing,  and
risk factors,  translated  into  Portuguese  and  validated  for  the
Brazilian population.14
To  perform  the  study,  the  coordinators  of  the  EISL  stipu-
lated that  the  sample  should  include  at  least  1,000  infants.
The sample  size  was  based  on  the  International  Study  of
Asthma and  Allergies  in  Childhood  (ISAAC),  considering  a
prevalence of  wheezing  of  30%  and  25%  in  two  different  cen-
ters, with  a  study  power  of  95%  and  a  signiﬁcance  level  of  1%
for  this  sample,  to  ensure  adequate  power  for  comparisons
between centers  and  countries,  even  for  questions  with  a
low prevalence  of  positive  answers.1,15
Infants  who  had  three  or  more  episodes  of  wheezing  were
deemed recurrent  wheezers  and  those  with  less  than  three
episodes of  wheezing  were  termed  occasional  wheezers.
Those who  never  had  a  wheezing  episode  were  classiﬁed
as non-wheezers.
Data were  coded  in  a  standard  way,  transferred  to  a
database developed  in  Microsoft  Excel®  2007,  and  statis-
tically analyzed  using  the  Statistical  Package  for  Social
Sciences (SPSS)  for  Windows  -  release  18.0.
Non-parametric  tests  were  used  (chi-squared  and  Fisher’s
exact test),  as  well  as  logistic  regression  model.  Estimates
of prevalence  ratio  with  a  95%  conﬁdence  interval  (95%  CI)
were calculated  in  the  bivariate  analysis.  The  Poisson  model
was used  for  the  logistic  regression  to  evaluate  the  factors
associated with  the  presence  or  absence  of  wheezing.  In  the
initial model,  the  variables  that  resulted  in  a  p  < 0.20  in  the
bivariate analysis  were  identiﬁed.  For  multivariate  analysis,
the backward  technique  was  used  and  the  test  for  variable
input and  output  was  the  likelihood  ratio,  with  p  <  0.05,  thus
determining the  ﬁnal  model.  All  signiﬁcance  probabilities
were bilateral,  with  a  signiﬁcance  level  of  0.05  in  all  tests.
This  study  was  approved  by  the  Ethics  Committee  of  the
Universidade Federal  de  São  Paulo/Escola  Paulista  de  Medi-
cina (UNIFESP/EPM)  and  the  Research  Ethics  Committee  of
the Hospital  Universitário  Júlio  Müller.
Results
A  total  of  1,060  parents  and/or  guardians  of  infants  aged
between 12  and  15  months  were  interviewed.  No  question-
naires were  excluded  from  the  sample  due  to  incorrect
completion. Most  responders  were  mothers  (87.9%),  fol-
lowed by  other  relatives  (6.4%),  and  fathers  (5.7%).  Five
hundred and  forty-six  (51.5%)  were  females  and  514  (48.5%)
were males.  Two  hundred  and  ninety-four  (27.7%)  infants
t
a
w
i561
ad  at  least  one  episode  of  wheezing  in  the  ﬁrst  year  of
ife (‘‘wheezers’’),  with  wheezing  onset  at  5.8±3.0  months.
mong the  wheezing  infants,  159  (54.1%)  had  less  than  three
pisodes (occasional  wheezing)  and  135  (45.9%)  had  three  or
ore episodes  (recurrent  wheezing).
Table  1  shows  the  factors  that  were  associated  with
heezing in  the  ﬁrst  12  months  of  life  in  the  bivariate
nalysis, which  were:  male  gender,  history  of  pneumonia
nd hospitalization  for  pneumonia,  exposure  to  maternal
moking during  pregnancy  and  passive  exposure  after  birth,
amily history  of  asthma,  daily  consumption  of  industrial-
zed foods,  breastfeeding  duration  between  two  and  four
onths, more  than  six  upper  respiratory  tract  infections
URTIs), having  the  ﬁrst  URTI  before  three  months  of  life,
iving in  a  moderately  polluted  environment,  presence  of  at
east one  sibling  in  the  household,  household  income  less
han R$  800.00,  use  of  antibiotics  for  pneumonia  and  skin
nfections, and  use  of  paracetamol  for  URTI.
Factors  associated  with  recurrent  wheezing  in  the  bivari-
te analysis  were:  antibiotics  for  bronchitis,  antibiotics  for
ny infection,  use  of  paracetamol  for  bronchitis,  and  para-
etamol use  more  than  seven  times  in  the  ﬁrst  year  of  life
Table 2).
Table 3  and  Fig.  1  show  the  results  of  the  multivariate
nalysis. Odds  ratios  (OR)  and  corresponding  95%  conﬁdence
ntervals (95%CI)  were  calculated.  Independent  risk  factors
ssociated with  the  presence  of  at  least  one  episode  of
heezing in  the  ﬁrst  year  of  life  were:  history  of  pneu-
onia, family  history  of  asthma  in  the  mother,  father  and
iblings, more  than  six  URTIs,  ﬁrst  URTI  before  three  months
f life,  living  in  a  moderately  polluted  environment,  antibi-
tic use  for  skin  infections,  and  paracetamol  use  for  URTIs.
he protective  factors  for  wheezing  in  the  ﬁrst  year  of  life
ere: C-section  delivery,  indoor  bathroom,  mother  having
aid work,  and  taking  antibiotics  for  pneumonia.
iscussion
enetic  and  environmental  factors  have  been  suggested  as
isk factors  for  wheezing  in  the  ﬁrst  years  of  life.  As  wheez-
ng is  the  main  symptom  of  asthma,  identifying  these  factors
n this  age  group  is  crucial  for  a  better  understanding  of
he different  wheezing  phenotypes  and  the  progression  to
sthma development.  The  results  of  this  study  point  to
everal genetic,  demographic,  and  environmental  factors
ssociated with  wheezing  in  the  ﬁrst  year  of  life.
Among  the  sociodemographic  factors,  male  gender  was
 risk  factor  for  the  occurrence  of  at  least  one  episode
f wheezing  in  infants  evaluated  in  the  bivariate  anal-
sis (Table  1).  Other  Brazilian  studies  also  found  this
ssociation.16,17 This  factor,  however,  did  not  remain  a  risk
actor in  the  multivariate  analysis;  a  similar  ﬁnding  was
bserved in  another  Brazilian  study.18
In  this  study,  the  presence  of  asthma  in  the  infants’  rela-
ives (mother,  father,  and  siblings)  was  associated  with  risk
f wheezing  in  the  ﬁrst  year  of  life  in  both  the  bivariate  and
ultivariate analyses.  In  a  Brazilian  cohort  study,  family  his-ory of  asthma  assessed  at  four  years  of  age  was  signiﬁcantly
ssociated with  the  pattern  of  transient  and  persistent
heezing.5 Other  studies  have  found  this  association16--18,
n agreement  with  the  Asthma  Predictive  Index  (API),  which
562  Moraes  LS  et  al.
Table  1  Factors  associated  with  the  presence  of  at  least  one  episode  of  wheezing  in  the  ﬁrst  12  months  of  life  (n  =  294)  in  the
bivariate  analysis.
Factors  n  PR  95%  CI  p
Male  gender  159  1.36  1.04-1.79  0.029
Pneumonia  80  3.90  2.72-5.58  0.000
Hospitalization  due  to  pneumonia  33  3.91  2.27-6.73  0.000
Passive  smoking  94  1.58  1.17-2.12  0.003
Maternal  smoking  during  pregnancy 16 2.15 1.10-4.20 0.023
Asthma  in  the  family
Father 37  1.79 1.16-2.77 0.012
Mother  57  1.58 1.11-2.26 0.015
Sibling  26  2.15  1.26-3.67  0.006
Daily  intake  of  industrialized  food  139  1.42  1.09-1.87  0.013
URTIs
≥  six  episodes  a  year 125 3.90  2.89-5.28  0.000
First  episode  before  three  months  of  life 86  2.06 1.50-2.82 0.000
First  episode  after  six  months  of  life 64  0.53 0.39-0.72 0.000
C-section  delivery 212 0.44 0.30-0.57 0.000
Mother’s  level  of  schooling:  complete  high
school  or  college/university
94 0.66 0.50-0.88 0.005
Air  conditioning  at  home  135  0.46  0.35-0.60  0.000
Indoor  bathroom  262  0.26  0.15-0.46  0.000
Live  in  a  moderately  polluted  environment  68  1.79  1.28-2.52  0.001
Have  at  least  one  sibling  180  1.50  1.14-1.97  0.005
Mother  has  a  job  138  0.63  0.48-0.83  0.001
Family  income  <  R$  800.00  71  2.25  1.60-3.17  0.000
Family  income  of  R$  3,500.00  to  R$  5,000.00  43  0.60  0.42-0.87  0.008
Updated  immunizations  266  0.47  0.28-0.78  0.005
Antibiotic  use
Due to  pneumonia 53  2.63  1.77-3.93  0.000
Due  to  otitis 49  1.76  1.20-2.56  0.004
Due  to  skin  infection 22 2.40  1.33-4.32  0.004
Paracetamol  use
Due to  URTIs  211  2.62  1.96-3.51  0.000
Due  to  pneumonia  22  4.68  2.33-9.43  0.000
Number  of  times  that  paracetamol  was  used
One  to  three  times  65  0.64  0.47-0.88  0.006
Seven  or  more  times  141  1.75  1.33-2.30  0.000
atory
h
d
t
(
w
a
w
t
o
a
c
w
s
-
L
i
o
e
c
o
o
r
l
s
n
f
iCI, conﬁdence interval; PR, prevalence ratio; URTIs, upper respir
as  parental  history  of  asthma  as  a  major  criterion  for  the
iagnosis of  asthma  in  children  with  recurrent  wheezing.19
The  presence  of  six  or  more  episodes  of  upper  respiratory
ract infections  in  the  ﬁrst  year  of  life,  with  early  onset
before three  months  of  age),  was  a  factor  associated  with
heezing in  this  study  (Tables  1  and  3).  The  presence  of
t least  one  sibling  in  the  house,  which  was  also  associated
ith wheezing  in  the  bivariate  analysis,  may  partly  explain
he early  occurrence  of  these  infections,  as  only  31  (10.5%)
f the  infants  who  had  at  least  one  episode  of  wheezing
ttended daycare  (data  not  shown).
Upper  and  lower  airway  infections,  particularly  those
aused by  RSV  and  rhinoviruses,  are  common  triggers  of
heezing in  childhood,  but  the  role  of  early  infection  in  the
ubsequent development  of  asthma  is  less  clear.20 The  EISL
 Phase  1,  which  involved  28,687  infants  from  countries  in
atin America  and  Europe,  observed  the  presence  of  URTI
(
i
f
i tract infections.
n  the  ﬁrst  three  months  of  life  among  the  risk  factors  for
ccasional and  recurrent  wheezing.1 A  cohort  study  that
valuated 2,319  infants  up  to  two  years  of  age  found  that
hildren who  had  common  colds  in  the  ﬁrst  three  months
f life  had  high  risk  for  experiencing  wheezing  in  the  sec-
nd year  of  life.21 Another  study  found  that  the  number  of
espiratory infections,  particularly  in  the  ﬁrst  two  years  of
ife, showed  an  almost  linear  association  with  the  risk  of
ubsequent asthma,  and  that  the  group  of  children  who  had
ine to  ten  infections  had  an  almost  eight-fold  higher  risk
or development  of  asthma.22
The  reporting  of  pneumonia  was  associated  with  wheez-
ng in  both  the  bivariate  and  multivariate  analyses
Tables 1  and  3).  As  this  was  a  cross-sectional  study,  wheez-
ng could  not  be  characterized  as  a  triggering  or  consequent
actor of  pulmonary  infections,  but  pneumonia  was  an
mportant risk  factor  in  this  study.  In  a  cohort  of  newborns  of
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Table  2  Factors  associated  with  occasional  (less  than  three  episodes  of  wheezing,  n  =  159)  and  recurrent  wheezing  (three  or
more  episodes  of  wheezing,  n  =  135)  in  the  ﬁrst  year  of  life  in  the  bivariate  analysis.
Variables  Wheezing  in  the  ﬁrst  year  of  life
Occasional  Recurrent
OR  95%  CI OR  95%  CI
Upper  respiratory  tract  infections
First episode  >  six  months  of  life 2.65 1.45-4.84  0.38  0.21-0.69
Use  of  antibiotics  in  the  ﬁrst  year  of  life
Due  to  bronchitis 0.42 0.26-0.68  2.36 1.46-3.81
Due to  any  other  infection 0.41 0.25-0.66  2.46 1.51-4.00
Use  of  paracetamol  in  the  ﬁrst  year  of  life
One  to  three  times  1.90  1.07-3.38  0.52  0.29-0.93
Seven  or  more  times  0.57  0.36-0.90  1.76  1.11-2.80
Due  to  bronchitis 0.48  0.27-0.84  2.08  1.18-3.64
CI, conﬁdence interval; OR, odds ratio.
Table  3  Factors  associated  with  wheezing  in  the  ﬁrst  year  of  life  in  the  multivariate  analysis  (n  =  294).
Variables  OR  95%  CI  pa
Pneumonia  10.80  4.52-27.77  0.000
Father  has  asthma  1.98  1.22-3.23  0.006
Mother  has  asthma  1.62  1.07-2.43  0.021
Sibling  has  asthma  2.13  1.18-3.87  0.013
C-section  delivery  0.66  0.45-0.98  0.037
Six  or  more  episodes  of  URTIs  2.95  2.11-4.14  0.000
First  URTI  before  three  months  of  life  1.50  1.04-2.17  0.029
Indoor  bathroom  0.41  0.22-0.76  0.005
Live  in  a  moderately  polluted  environment  1.59  1.08-2.33  0.018
Mother  has  a  job  0.66  0.48-0.90  0.009
Antibiotic  use  due  to  pneumonia  0.22  0.08-0.56  0.002
Antibiotic  use  due  to  skin  infection  2.29  1.18-4.46  0.015
Paracetamol  use  due  to  URTI  2.13  1.54-2.95  0.000
CI, conﬁdence interval; OR, odds ratio; URTIs, upper respiratory tract infections.
a Signiﬁcant values.
Pneumonia (OR=10.80 ) 0.000
Father has asthma (OR=1.98 ) 0.006
Mother has asthma (OR=1.62 ) 0.021
Siblings have asthma (OR=2.1 3) 0.013
C-section delivery (OR=0.66 ) 0.037
Six or more episodes of URTIs (OR=2.9 5) 0.000
URTI in the first three months of life (OR=1.50 ) 0.02 9
Indoor bathroom (OR=0.41 ) 0.005
Live in a moderately polluted area (OR=1.59) 0.018
Mother has a job (OR=0.66 ) 0.009
Antibiotic use due to pneumonia (OR=0.2 2) 0.002
Antibiotic use due to skin infection (OR=2.29 ) 0.01 5
Paracetamol use due to URTI (OR=2.13 ) 0.000
OR: odds ratio; URTI: Upper respiratory tract infection
pRiskProtection
Wheezing
1.51.00.50.0 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0
Figure  1  Risk  and  protective  factors  for  wheezing  in  the  ﬁrst  year  of  life.
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ow  socioeconomic  class  in  Santiago  (Chile),  followed  during
he ﬁrst  year  of  life,  a  prevalence  of  pneumonia  of  13.3%,
as observed,  and  the  presence  of  recurrent  wheezing  dur-
ng the  ﬁrst  three  months  of  life  was  strongly  associated  with
he diagnosis  of  pneumonia.23 EISL  publications  in  Brazil  also
ound the  presence  of  pneumonia  in  the  ﬁrst  year  of  life  as
 risk  factor  associated  with  wheezing.17,18,24
In  the  present  study,  exposure  to  maternal  smoking
uring pregnancy  and  passive  exposure  after  birth  was  asso-
iated with  wheezing  only  in  the  bivariate  analysis  (Table  1).
he multivariate  analysis  did  not  conﬁrm  this  association,
hich can  be  explained  by  the  low  frequency  of  mothers
f wheezing  infants  who  smoked  during  pregnancy  (5.4%)  or
fter birth  (7.5%).  There  is  a  tendency  towards  undernotiﬁ-
ation of  the  frequency  of  smoking  by  parents  and  caregivers
f children  with  respiratory  diseases,  as  they  know  the  harm-
ul effects  of  smoking  on  the  respiratory  system.
Obtaining  objective  measures  of  this  exposure  could  min-
mize this  bias.  Exposure  to  cigarette  smoke,  both  in  the
renatal period  and  after  birth,  was  associated  with  the
isk of  wheezing  in  infants  and  preschool  children  in  sev-
ral studies.1,17,25 A  meta-analysis  observed  that  prenatal  or
ostnatal exposure  increased  the  risk  of  incidence  of  wheez-
ng by  30%  to  70%,  mainly  in  children  younger  than  two
ears, stressing  that  parental  smoking  prevention  is  crucial
or asthma  prevention.7
The  present  study  demonstrated  that  living  in  a  moder-
tely polluted  environment  was  a  risk  factor  for  wheezing
n the  ﬁrst  year  of  life,  similar  to  that  observed  in  other
tudies.18,26 Exposure  to  pollutants  may  be  associated  with
espiratory symptoms  such  as  wheezing,  not  only  as  a  trigg-
ring factor,  but  also  as  a  risk  factor  for  the  development  of
sthma, according  to  the  results  of  a  cohort  study  of  4,089
wedish children,  which  demonstrated  that  exposure  to  air
ollution from  trafﬁc  during  the  ﬁrst  year  of  life  was  associ-
ted with  risk  of  persistent  wheezing  and  low  lung  function
t the  age  of  4  years.27 In  a  Chilean  cohort  study,  the  preva-
ence of  wheezing  in  the  ﬁrst  year  of  life  was  high  (80.3%),
nd it  was  observed  that  82.2%  of  the  children  were  exposed
o pollutants  resulting  from  the  fuel  used  for  heating  or
ooking (kerosene,  gas),  and  that  38.5%  of  the  homes  were
ocated on  unpaved  roads.23 As  the  pollution  exposure  was
nown only  through  parental  report,  this  result  must  be  ana-
yzed with  caution,  as  it  lacks  objective  measures  to  assess
he degree  of  intra-  and  extra-domiciliary  environment  pol-
ution.
In this  study,  the  use  of  drugs  such  as  paracetamol  and
ntibiotics was  associated  with  the  risk  of  recurrent  wheez-
ng (Table  2)  and  of  wheezing  in  the  ﬁrst  year  of  life  (Table  3).
A  prospective  study  that  followed  children  with  a  family
istory of  atopy,  from  birth  to  7  years  of  age,  found  an  asso-
iation between  frequency  of  paracetamol  use  and  asthma
evelopment, which  was  not  maintained  after  adjustment
or the  frequency  of  respiratory  infections,  suggesting  a
onfounding factor  i.e.,  it  is  likely  that  the  viral  infec-
ions in  early  childhood,  more  than  the  use  of  paracetamol,
ay lead  to  the  development  of  asthma.28 However,  in
nother study,  the  association  between  asthma  and  para-
etamol use  persisted  even  after  adjusting  for  respiratory
nfections.29 A  cohort  study  that  evaluated  the  use  of  para-
etamol during  pregnancy  observed  that  the  use  of  this  drug
as associated  with  the  presence  of  asthma  at  age  ﬁve  and
d
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he  risk  was  higher  in  those  who  had  a  greater  number  of
ays of  consumption,  suggesting  a  possible  dose-dependent
ssociation.30
Therefore,  the  association  between  paracetamol  and
heezing/asthma may  simply  reﬂect  a  reverse  causality,  i.e.
hildren with  a  genetic  predisposition  to  asthma  or  other
llergies are  more  prone  to  febrile  comorbidities,  particu-
arly URTI  and  therefore  use  more  antipyretic  medications
uch as  acetaminophen.11 Thus,  the  association  between
aracetamol and  wheezing/asthma  requires  further  stud-
es, using  more  appropriate  designs  that  can  attenuate  or
liminate potential  confounding  biases.
The  use  of  antibiotics  was  a  risk  factor  for  wheezing,  and
his can  be  explained  in  part  by  the  ‘‘hygiene  hypothesis’’,
hich suggests  that  children  who  grow  up  in  an  environment
ith less  microbial  exposure  tend  to  be  more  atopic  and
herefore have  a  greater  chance  of  developing  asthma.31 A
eta-analysis study  observed  that  exposure  to  at  least  one
ourse of  antibiotics  in  the  ﬁrst  year  of  life  was  a  risk  fac-
or for  the  development  of  asthma  in  childhood.32 A  cohort
tudy of  251,817  Canadian  children  followed  from  birth,
valuated for  exposure  to  antibiotics  in  the  ﬁrst  year  of  life,
bserved a  lower  risk  for  developing  asthma,  but  this  risk
ncreased greatly  when  the  child  received  more  than  four
ourses of  antibiotics  in  the  study  period.33 Another  recent
eta-analysis evaluating  antibiotic  exposure  in  the  prena-
al period  and  the  ﬁrst  year  of  life  found  an  association  with
sthma from  ages  3  to  18  years.34
In  fact,  several  studies  show  a  signiﬁcant  association
etween the  use  of  antibiotics  in  early  childhood  and  sub-
equent development  of  wheezing/asthma;  conversely,  the
se of  antibiotics  may  be  a  consequence  of  the  increased
requency of  respiratory  infections  in  children  with  allergic
redisposition, which  is  postulated  as  reverse  causality,  and
his may  complicate  the  interpretation  of  several  epidemi-
logical studies;  therefore,  further  studies  are  needed  to
lucidate this  association.
The present  study  had  some  limitations  that  should  be
onsidered when  interpreting  the  results.  As  this  was  a
ross-sectional study,  the  associations  observed  cannot  be
onsidered as  causalities,  and  prospective  studies  are  neces-
ary to  better  clarify  the  correlation  between  risk  factors  for
heezing and/or  asthma.  A  strong  aspect  of  the  study  was
hat the  information  regarding  the  wheezing  that  occurred
n the  ﬁrst  12  months  of  life  was  obtained  when  the  infants
ere 12  to  15  months,  thereby  decreasing  the  likelihood  of
ecall bias.  Other  important  aspects  of  this  study  were  the
ample size  and  the  use  of  a  standardized  questionnaire  that
llowed for  the  comparison  between  the  different  centers
hich performed  the  study.
In  conclusion,  this  study  demonstrated  that  some  factors
ere associated  with  risk  of  wheezing  in  the  ﬁrst  year  of  life,
uch as  family  history  of  asthma,  pneumonia,  more  than  six
pisodes  of  upper  respiratory  infections  in  early  life,  liv-
ng in  a  polluted  environment,  and  use  of  paracetamol  and
ntibiotics. These  factors  varied  when  compared  with  other
razilian studies  that  used  the  same  protocol,  which  rein-
orces the  need  for  further  studies  in  other  cities  of  Brazil
ue to  the  environmental  particularities  of  each  region.
rospective follow-ups  of  wheezing  infants  are  needed  to
nalyze the  impact  of  these  risk  factors  over  the  long-term
n Brazil.  The  identiﬁcation  of  risk  factors  for  wheezing  in
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the  ﬁrst  years  of  life  is  crucial  not  only  for  the  diagno-
sis of  asthma,  but  also  for  the  development  of  prevention
strategies through  public  health  policies  aiming  to  minimize
wheezing morbidity  in  childhood.
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